Latest Becker's muscular dystrophy Stories
After 5 Years at White Rock Lake, Local Outreach Effort and Fundraiser Moves to a Larger Stage DALLAS, Oct.
AMSTERDAM, September 24, 2010 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT), a leader in the field of human gene therapy, announced today that the U.S.
$11 Million Supports Five-Year Study to Compare Treatments ROCHESTER, N.Y., Sept.
Dr. Jerry Mendell Leading Follistatin Gene Therapy MIDDLETOWN, Ohio, Aug.
Funds Will Help Offset Travel Costs for Participants MIDDLETOWN, Ohio, July 14 /PRNewswire-USNewswire/ -- Patricia A.
Conference Includes Launch of First-Ever Duchenne Therapeutic Development Meeting MIDDLETOWN, Ohio, June 18 /PRNewswire-USNewswire/ -- Patricia A.
Dr. Dongsheng Duan and Nicholas Dobes to Receive Grants MIDDLETOWN, Ohio, June 10 /PRNewswire-USNewswire/ -- Patricia A.
One in 25 people from India and other south Asian countries carries a mutated gene that causes heart failure.
Rep. Thomas R.
MIDDLETOWN, Ohio, May 7 /PRNewswire-USNewswire/ -- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Neurological Disorders and Stroke (NINDS) are launching a five-year, $7.5 million natural history study of Duchenne muscular dystrophy (Duchenne), a degenerative genetically-linked neuromuscular disease.
- The act of sweetening by admixture of some saccharine substance.